BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $357,000 | -91.1% | 4,600 | -90.8% | 0.00% | -87.1% |
| Q4 2020 | $4,012,000 | -66.3% | 50,000 | -66.3% | 0.03% | -78.2% |
| Q3 2020 | $11,917,000 | -21.8% | 148,186 | -16.3% | 0.14% | -17.4% |
| Q2 2020 | $15,239,000 | +227.7% | 176,993 | +209.1% | 0.17% | +244.0% |
| Q1 2020 | $4,650,000 | -20.6% | 57,264 | -18.2% | 0.05% | +11.1% |
| Q4 2019 | $5,853,000 | -39.2% | 70,000 | -40.5% | 0.04% | -52.6% |
| Q2 2019 | $9,632,000 | +241.1% | 117,600 | +174.1% | 0.10% | +90.0% |
| Q4 2018 | $2,824,000 | +850.8% | 42,905 | +1013.0% | 0.05% | +1566.7% |
| Q3 2018 | $297,000 | -97.1% | 3,855 | -97.6% | 0.00% | -96.4% |
| Q1 2018 | $10,343,000 | -13.1% | 159,028 | -13.6% | 0.08% | +38.3% |
| Q4 2017 | $11,904,000 | +10.6% | 184,155 | +7.4% | 0.06% | +25.0% |
| Q3 2017 | $10,762,000 | -68.7% | 171,500 | -69.8% | 0.05% | -74.5% |
| Q2 2017 | $34,331,000 | -14.0% | 567,100 | -26.4% | 0.19% | -37.3% |
| Q1 2017 | $39,941,000 | +4988.0% | 770,159 | +4251.2% | 0.30% | +3650.0% |
| Q4 2016 | $785,000 | -91.3% | 17,700 | -90.7% | 0.01% | -90.6% |
| Q3 2016 | $9,029,000 | +3930.8% | 189,700 | +3734.6% | 0.08% | +2025.0% |
| Q2 2016 | $224,000 | -98.8% | 4,947 | -99.0% | 0.00% | -97.7% |
| Q4 2015 | $18,670,000 | +56.2% | 489,361 | +34.5% | 0.17% | +23.7% |
| Q3 2015 | $11,951,000 | +51.5% | 363,800 | +222.5% | 0.14% | +90.4% |
| Q2 2015 | $7,888,000 | +3132.8% | 112,800 | +3110.9% | 0.07% | +812.5% |
| Q4 2013 | $244,000 | – | 3,513 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |